stocktools
Offerings // enGene Therapeutics Inc.

ENGN offering history

Every offering-related filing in enGene Therapeutics Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 267 filings back to Jun 14, 2023.

Last executed offering
Mar 9, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Feb 19, 2026
S-3 — capacity, not a sale
Executed, last 12 months
4
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Mar 9, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 2, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 19, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jan 21, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Nov 14, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 12, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 20, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 21, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 21, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 21, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 21, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 13, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Nov 13, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Oct 28, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 25, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 21, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 26, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 10, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 24, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 14, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 15, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 25, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 12, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 5, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 27, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Feb 14, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 28, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 15, 2023S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Nov 22, 2023S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 31, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 2, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 29, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
ENGN offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ENGN workspace →
ENGN offering FAQ

When did ENGN last execute an offering?

Per SEC filings, enGene Therapeutics Inc.'s most recent priced offering document is a 424B5 filed 2026-03-09. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ENGN last announce or register an offering?

The most recent registration is a S-3 filed 2026-02-19. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.